IL7/IL7R-mediated binding activates three main signaling pathways: Jak/STAT, MAPK/Erk and PI3K/Akt/mammalian target of rapamycin (mTOR) [32] in both T-ALL and healthy T-cells [33,34]. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.